3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Neoplasms
3
Leukemia
2
Endometrial Neoplasms
2
Toxoplasmosis
1
Thrombocytosis
1
Myeloproliferative Disorders
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia, Eosinophilic, Acute
1
Leukemia, Basophilic, Acute
1
Congenital Abnormalities
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Carcinoma, Renal Cell
1
Adenomyosis
1
Adenocarcinoma of Lung
1
Interventions
Rituximab
55
Cyclophosphamide
38
Vincristine
25
Prednisone
24
Doxorubicin
21
Cytarabine
18
Etoposide
17
Lenalidomide
16
Gemcitabine
12
Melphalan
8
Filgrastim
8
Cisplatin
8
Peripheral Blood Stem Cell Transplantation
7
Oxaliplatin
7
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
7
Methotrexate
7
Ifosfamide
7
Carmustine
7
zanubrutinib
6
R-CHOP protocol
6
Vindesine
5
Radiotherapy
5
Dexamethasone
5
Busulfan
5
ibrutinib
4
fludarabine phosphate
4
Methylprednisolone
4
Epirubicin
4
Decitabine
4
Cyclosporine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Lymphoma, Large B-Cell, Diffuse
×
Base Sequence
×
Clear all
NCT04183569
2020-04-29
PROTEOM
University Hospital, Bordeaux
Unknown
32 enrolled